免疫基治疗的新时代 肝脏内胆瘤的新时代
Etsushi Kawamura1, Tsutomu Matsubara2, Norifumi Kawada1
1Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Cancers
|August 12, 2023
概括
加上杜尔瓦卢马布免疫疗法加上吉姆西塔宾加上西斯普拉丁化学疗法是胆道癌 (BTC) 的新标准一线治疗方法,显著改善了生存率. 分子造型指南针对晚期肝内胆管癌 (CC) 的向治疗方法.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝脏内胆管癌 (CC) 是胆管癌 (BTC) 的一个子集,预后不佳.
- 目前无法切除的BTC的治疗选择有限,切除病例的5年生存率约为20%.
- 自2010年以来,吉姆西塔加西斯普拉丁化疗一直是标准的第一线治疗方法.
研究的目的:
- 审查肝脏内CC的全身药物治疗策略.
- 在BTC中介绍免疫检查点抑制剂治疗的临床试验结果.
- 突出BTC管理和向治疗开发方面的进展.
主要方法:
- 临床试验的审查,重点是TOPAZ-1第三阶段试验.
- 在BTC治疗中对免疫检查点抑制剂的结果分析.
- 讨论分子分析和针对肝脏内CC的向治疗方法.
主要成果:
- 添加杜尔瓦卢马布 (durvalumab) 于吉姆西塔 (gemcitabine) 加西斯普拉丁 (cisplatin) 显著改善了BTC患者的存活率,而不会增加毒性.
- 这三种药物组合代表了一种新的标准一线治疗,这是自2010年以来的重大进展.
- 有针对性治疗可用于肝脏内CC的特定基因组变化,指导二线治疗决策.
结论:
- 杜尔瓦卢马布加上吉姆西塔/西斯普拉丁是BTC的新标准一线治疗方法.
- 分子分析对于选择针对性治疗在先进的肝内CC中至关重要.
- 免疫疗法和向医学的进步正在改善BTC患者的治疗结果.
相关概念视频
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


